Screening determination of thyroid stimulating hormone in diagnosis of subclinical hypothyroidism in pregnant women: versions and contraversions
https://doi.org/10.33667/2078-5631-2020-34-59-65
Abstract
The work is devoted to the necessity of conducting a screening study of thyroid function in women in the pre-gravidar period and during gestation. Pathological conditions of the thyroid gland are one of the most common diseases of the endocrine system, second only to diabetes mellitus in prevalence. At the same time, in recent years, there has been an increase in thyroid insufficiency. Clinical and subclinical hypothyroidism are the most common hormonal dysfunctions during pregnancy, which have a negative impact on the course of gestation and fetal development. At the same time, subclinical hypothyroidism is an easily treatable disease that reduces the pregnancy related morbidity of the mother and fetus. Screening only at-risk patients probably skips most cases. Therefore, guidelines should be established for universal screening of thyroid dysfunction in the pre-gravidar period and during pregnancy with their own ranges for thyroid stimulating hormone during gestation, calculated taking into account regional, ethnic and population characteristics. Levothyroxine replacement therapy in a woman with subclinical hypothyroidism in the pre-gravidar period and during pregnancy should begin immediately after the diagnosis of this condition and be adequate in terms of timing and dose.
About the Author
S. V. Khabarov
Tula State University; Federal Scientific and Clinical Centre for Specialized Medical Care and Medical Technologies; Vitromed Co.
Russian Federation
Tula; Moscow
Russian Federation
Tula; Moscow
References
1. Хабаров С. В. Тиреотропный гормон и гормоны щитовидной железы. Клиническая лабораторная диагностика: учебное пособие. С. В. Хабаров, О. В. Денисова. ИП Колмогоров И. А. (Новый формат), 2019. 96 с.
2. Шустов С. Б., Халимов Ю. Ш., Труфанов Г. Е. Функциональная и топическая диагностика в эндокринологии. 2-е изд., перераб. и доп. СПб.: Элби-СПб, 2010. 296 с.: ил.
3. López-Muñoza E., Mateos-Sánchez L., Mejía-Terrazasa G.E., Bedwell-Cordero S. E. Hypothyroidism and isolated hypothyroxinemia in pregnancy, from physiology to the clinic. Taiwan. J. Obstet. Gynecol. 2019; 58 (6): 757–776. https://doi.org/10.1016/j.tjog.2019.09.005
4. Salek T., Dhaifalah I., Langova D., Havalova J. The prevalence of maternal hypothyroidism in first trimester screening from 11 to 14 weeks of gestation. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech. Repub. 2019; 163 (3): 265–268. https://doi.org/10.5507/bp.2018.063
5. Древаль А. В. Заболевания щитовидной железы и беременность. А. В. Древаль, Т. П. Шестакова, О. А. Нечаева. М.: ОАО «Издательство «Медицина», 2007. 80 с. 6 ил.
6. Вербовой А. Ф. Гипотиреоз. А. Ф. Вербовой, Л. А. Шаронова, Ю. А. Долгих. М.: ГЭОТАР-Медиа, 2016. 80 с.: ил.
7. Хабаров С. В. Беременность и заболевания щитовидной железы: учебное пособие. С. В. Хабаров, В. Г. Волков, К. А. Хадарцева. ИП Колмогоров И. А. (Новый формат), 2019. 102 с.
8. Эндокринные заболевания и беременность в вопросах и ответах. Руководство для врачей. под ред. И. И. Дедова, Ф. Ф. Бурумкулова. М.: Е-ното, 2015. 272 с.
9. Гончаров Н. П. Гормональный анализ в диагностике болезней эндокринных желез. Н. П. Гончаров, Г. В. Кация, Г. С. Колесникова, А. Д. Добрачева. 2-е изд., доп. и перераб. М.: Издательство «АдамантЪ», 2017. 364 с.
10. Sitoris G., Veltri F., Kleynen P., Belhomme J., Rozenberg S., Poppe K. Screening for Thyroid Dysfunction in Pregnancy With Targeted High-Risk Case Finding: Can It Be Improved? J. Clin. Endocrinol. Metab. 2019; 104 (6): 2346–2354. https://doi.org/10.1210/jc.2018–02303
11. Veltri F., Poppe K. Variables Contributing to Thyroid (Dys)Function in Pregnant Women: More than Thyroid Antibodies? Eur. Thyroid. J. 2018; 7 (3): 120–128. https://doi.org/10.1159/000488279
12. Harding K. B., Peña-Rosas J.P., Webster A. C., Yap C. M.Y., Payne B. A., Ota E., De-Regil L. M. Iodine supplementation for women during the preconception, pregnancy and postpartum period (Review). Cochrane Database Syst. Rev. 2017; 3: CD 011761. https://doi.org/10.1002/14651858.CD 011761.pub2.
13. Lazarus J., Brown R. S., Daumerie Ch., Hubalewska-Dydejczyk A., Negro R., Vaidya B. 2014 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children. Eur. Thyroid. J. 2014; 3: 76–94. https://doi.org/10.1159/000362597
14. Трошина Е. А., Платонова Н. М., Панфилова Е. А., Панфилов К. О. Аналитический обзор по результатам мониторинга основных эпидемиологических характеристик йододефицитных заболеваний у населения Российской Федерации за период 2009–2015 гг. Проблемы эндокринологии. 2018; 64 (1): 21–37. https://doi.org/10.14341/probl9308
15. Stagrano-Green A., Abalovich M., Alexander E., Azizi F., Mestman J., Negro R., Nixon A., Pearce E. N., Soldin O. P., Sullivan S., Wiersinga W. Guidline of the American Thyroid Assosiation for the diagnosis and management of Thyroid disease during pregnancy and postpartum. Thyroid. 2011; 21 (10): 1086–1088. https://doi.org/10.1089/thy.2011.0087
16. Alexander E. K., Pearce Е. N., Brent G. A., Brown R. S., Chen H., Dosiou Ch., Grobman W. A., Laurberg P., Lazarus J. H., Mandel S. J., Peeters R. P., Sullivan S. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017; 27 (3): 315–389. https://doi.org/10.1089/thy.2016.0457
17. Прегравидарная подготовка. Клинический протокол Междисциплинарной ассоциации специалистов репродуктивной медицины (МАРС). Версия 2.0 [Коллектив авторов]. М.: Редакция журнала StatusPraesens, 2020. 128 с.
18. Нормальная беременность. Клинические рекомендации МЗ РФ, 2020. 68 с.
19. Gietka-Czernel M., Glinicki P. Subclinical hypothyroidism in pregnancy: controversies on diagnosis and treatment. Polskie Arch. Med. Wewnetrznej. 2020; September 25. https://doi.org/10.20452/pamw.15626
20. Yamamoto J. M., Metcalfe A, Nerenberg K. A., Khurana R., Chin A., Donovan L. E. Thyroid function testing and management during and after pregnancy among women without thyroid disease before pregnancy. CMAJ. 2020; 192 (22): 596–602. https://doi.org/10.1503/cmaj.191664
21. Coene K. L., Demir A., Broeren M., Verschuure P., Lentjes E., Boer A. Subclinical hypothyroidism: a ‘laboratory-induced’ condition? Eur. J. Endocrinol. 2015; 173 (4): 499–505. https://doi.org/10.1530/EJE-15–0684
22. Taylor P. N., Zouras S., Min T., Nagarahaj K., Lazarus J. H., Okosieme O. Thyroid Screening in Early Pregnancy: Pros and Cons. Front. Endocrinol. 2018; 9: 626. https://doi.org/10.3389/fendo.2018.00626
23. Wu Mei-qin, Liu J., Wang Ya-Qian, Yang Y., Yan C., Hua J. The Impact of Subclinical Hypothyroidism on Adverse Perinatal Outcomes and the Role of Thyroid Screening in Pregnancy. Front. Endocrinol. 2019; 10 (522). https://doi.org/10.3389/fendo.2019.00522
24. Вспомогательные репродуктивные технологии и искусственная инсеминация. Клинические рекомендации МЗ РФ, 2019. 68 с.
25. Приказ МЗ РФ от 01.11.2012 г. № 572н «Об утверждении Порядка оказания медицинской помощи по профилю «акушерство и гинекология (за исключением использования вспомогательных репродуктивных технологий)».
26. Çakmak B., Turker Ulku A., Temur M., Ustunyurt E. Pregnancy outcomes of antibody negative and untreated subclinical hypothyroidism. J. Obstet. Gynaecol. Res. 2019; 45 (4): 8100816. https://doi.org/10.1111/jog.13925
27. Maraka S., Ospina N. M., O’Keeffe D.T., Espinosa De Ycaza A. E., Gionfriddo M. R., Erwin P. J., Coddington C. C., Stan M. N., Murad M. H., Montori V. M. Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis. Thyroid. 2016; 26 (4): 580–590. https://doi.org/10.1089/thy.2015.0418
28. Consortium on Thyroid and Pregnancy – Study Group on Preterm Birth, Korevaar T. I.M., Derakhshan A., et al. Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Meta-analysis. JAMA. 2019; 322 (7): 632–641. https://doi.org/10.1001/jama.2019.10931.
29. Batistuzzo A., Ribeiro M. O. Clinical and subclinical maternal hypothyroidism and their effects on neurodevelopment, behavior and cognition. Arch. Endocrinol. Metab. 2020; 64 (1): 89–95. https://doi.org/10.20945/2359–3997000000201
30. Шестакова Т. П. Субклинический гипотиреоз и беременность. РМЖ Мать и дитя. 2018; 5 (I): 56–60.
31. Veltri F., Belhomme J., Kleynen P. Grabczan L., Rozenberg S. Pepersack T. Poppe K. Maternal thyroid parameters in pregnant women with different ethnic backgrounds: Do ethnicity-specific reference ranges improve the diagnosis of subclinical hypothyroidism? Сlin. Endocrinol. (Oxf). 2017; 86 (6) 830–836. https://doi.org/10.1111/cen.13340
32. Sun X., Hou N., Wang H., Ma L., Sun J., Liu Y. (2019). A Meta-Analysis of Pregnancy Outcomes with Levothyroxine Treatment in Euthyroid Women with Thyroid Autoimmunity. J. Clin. Endocrinol. Metab. 2020; 105 (4): dgz217. https://doi.org/10.1210/clinem/dgz21
33. Mintziori G., Goulis D. G. (2014). European Thyroid Association guidelines in comparison with the American Thyroid Association and Endocrine Society practice guidelines for the screening and treatment of hypothyroidism during pregnancy. Hormones (Athens, Greece). 2015; 14 (1): 174–175. https://doi.org/10.14310/horm.2002.1554
34. В. Е. Радзинский, М. Б. Хамошина, О. А. Раевская и др. Очерки эндокринной гинекологии. Под ред. В. Е. Радзинского. М.: Редакция журнала StatusPraesens, 2020. 576 с.
35. Приказ МЗ РФ от 30.08.2012 г. № 107н «О порядке использования вспомогательных репродуктивных технологий, противопоказаниях и ограничениях к их применению».
Review
For citations:
Khabarov S.V. Screening determination of thyroid stimulating hormone in diagnosis of subclinical hypothyroidism in pregnant women: versions and contraversions. Medical alphabet. 2020;(34):59-65. (In Russ.) https://doi.org/10.33667/2078-5631-2020-34-59-65
Views:
379
Email this article 